HSPCs polarize in contact with bone marrow stromal cells constituting their niche. This study analyses the polarity of ...

Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated ...

How Breast Cancer Cells Survive in Bone Marrow After Remission Dec. 4, 2024 — A new study has shed light on a previously poorly understood aspect of breast cancer recurrence: how cancer cells ...

In An Exercise in Uncertainty, Jon Gluck traces decades of waiting, watching, enduring experimental treatment, and ...

While the embryonic limb bud expresses PDGFRα, its role during limb development is unknown. Here, the authors show that elevated PDGFRα signaling causes joint fusion in mice, as joint ...

The status has been given to the B7-H3-targeted drug as a treatment for late-line relapsed or refractory osteosarcoma, a rare form of bone cancer with no FDA-approved treatments. The coveted ...